📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-30 13:36
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
92 announcements match the current filters (relevance ≥ 5).
Rainbow executes 60-year lease for 250-bed pediatric hospital in Amaravati, AP
Rainbow Children's Medicare has signed a 60-year lease agreement with the Andhra Pradesh Capital Region Development Authority (APCRDA) for ~2 acres of land in Amaravati. The company plans to construct a 250-bed super speciality children's hospital and perinatal care facility, to be developed in a phased manner. Capex outlay and exact commissioning timelines were not disclosed in the filing. This project reinforces Rainbow's footprint in Andhra Pradesh alongside existing locations like Vijayawada, Visakhapatnam, and Rajahmundry.
Confidence: HIGH
What changedRainbow signed a definitive 60-year land lease agreement with APCRDA to build a greenfield hospital in Amaravati.
Why it mattersA 250-bed expansion expands long-term operational capacity and cements the company's leading market position in specialized pediatric and perinatal healthcare in Andhra Pradesh.
Lease area: approximately 2 acresLease tenure: 60 yearsPlanned capacity: 250-bedProject Capex: not disclosed
📅 Short termNeutral to mildly positive sentiment on pipeline expansion; no immediate impact on earnings as construction will take several quarters.
📈 Long termStrengthens regional presence in Andhra Pradesh's developing capital city, supporting medium-to-long term bed count and revenue growth as the capacity gets commissioned in phases.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution and regulatory delays inherent to greenfield construction
- Amaravati urban development pace and local patient ramp-up risks
- Capex details and break-even timelines not yet quantified
Key Highlights
Leased approximately 2 acres of land from APCRDA in Amaravati, Andhra Pradesh
Lease tenure established for 60 years
Planned capacity of 250 beds for a super speciality children's and perinatal care hospital
Project to be executed in a phased manner; capex investment not disclosed
👀 What to Watch
Track subsequent filings or quarterly earnings calls for project capex commitments, phased funding mechanisms, and construction timelines for the Amaravati facility.
Rainbow Appoints Sudarshan Patodia as Group CFO Effective September 23, 2026
Rainbow Children’s Medicare Limited announced the appointment of Mr. Sudarshan Patodia as Chief Financial Officer and Key Managerial Personnel, designated as Group CFO, effective September 23, 2026. Mr. Patodia brings nearly 20 years of finance experience, having previously served as CFO of New Delhi Centre for Sight Limited, VP of Finance at Vishal Mega Mart, and 14 years at ITC Limited. The Board of Directors also approved amendments to the company's Policy on Determination of Materiality of Events/Information. The CFO transition comes as Rainbow manages an annual revenue base of Rs 1,820 crore (TTM) with ongoing capacity expansions across North India.
Confidence: HIGH
What changedMr. Sudarshan Patodia has assumed the role of Group Chief Financial Officer and Key Managerial Personnel effective September 23, 2026.
Why it mattersA stable CFO leadership is crucial as the hospital chain deploys cash toward NCR expansions, integrates acquisitions, and manages TTM revenues of Rs 1,820 crore.
Effective Date of Appointment: September 23, 2026Prior Tenure at ITC Limited: approximately 14 yearsTotal Industry Experience: nearly two decades
📅 Short termRoutine leadership transition with minimal immediate impact on market sentiment or daily operations.
📈 Long termHis background in healthcare M&A and fundraising will be relevant to Rainbow's ongoing geographical expansion beyond South India.
Key Highlights
Appointment of Mr. Sudarshan Patodia as CFO and Group CFO effective September 23, 2026
Appointee brings nearly 20 years of finance experience across healthcare, retail, and FMCG sectors
Previously served as CFO at Centre for Sight and spent 14 years in various finance roles at ITC Limited
Board meeting conducted on September 23, 2026, commencing at 5:30 PM and concluding at 5:45 PM
👀 What to Watch
Track the upcoming quarterly earnings commentary to assess the new Group CFO's capital allocation and expansion execution strategy.
Rainbow Appoints Sudarshan Patodia as Group CFO Effective September 23, 2026
Rainbow Children’s Medicare Limited announced the appointment of Mr. Sudarshan Patodia as Chief Financial Officer and Key Managerial Personnel, designated as Group CFO, effective September 23, 2026. Mr. Patodia brings nearly 20 years of finance experience, having previously served as CFO of New Delhi Centre for Sight Limited, VP of Finance at Vishal Mega Mart, and 14 years at ITC Limited. The Board of Directors also approved amendments to the company's Policy on Determination of Materiality of Events/Information. The CFO transition comes as Rainbow manages an annual revenue base of Rs 1,820 crore (TTM) with ongoing capacity expansions across North India.
Confidence: HIGH
What changedMr. Sudarshan Patodia has assumed the role of Group Chief Financial Officer and Key Managerial Personnel effective September 23, 2026.
Why it mattersA stable CFO leadership is crucial as the hospital chain deploys cash toward NCR expansions, integrates acquisitions, and manages TTM revenues of Rs 1,820 crore.
Effective Date of Appointment: September 23, 2026Prior Tenure at ITC Limited: approximately 14 yearsTotal Industry Experience: nearly two decades
📅 Short termRoutine leadership transition with minimal immediate impact on market sentiment or daily operations.
📈 Long termHis background in healthcare M&A and fundraising will be relevant to Rainbow's ongoing geographical expansion beyond South India.
Key Highlights
Appointment of Mr. Sudarshan Patodia as CFO and Group CFO effective September 23, 2026
Appointee brings nearly 20 years of finance experience across healthcare, retail, and FMCG sectors
Previously served as CFO at Centre for Sight and spent 14 years in various finance roles at ITC Limited
Board meeting conducted on September 23, 2026, commencing at 5:30 PM and concluding at 5:45 PM
👀 What to Watch
Track the upcoming quarterly earnings commentary to assess the new Group CFO's capital allocation and expansion execution strategy.
Rainbow Children's Commences Operations at 50-Bed Hospital in Guntur, Andhra Pradesh
Rainbow Children's Medicare Limited has announced the commencement of operations at its newly established 50-bed women's and children's hospital in Guntur, Andhra Pradesh. This follows the company's prior disclosure on July 29, 2026, regarding the project. The operational launch expands Rainbow's footprint in Andhra Pradesh, supporting its cluster-based regional presence alongside cities like Vijayawada and Visakhapatnam.
Confidence: HIGH
What changedRainbow Children's has transitioned its new hospital facility in Guntur from the setup stage to active commercial operations.
Why it mattersAdds incremental operational bed capacity and deepens market penetration in Andhra Pradesh, contributing to long-term inpatient and outpatient revenue growth.
Bed capacity added: 50-bedAnnouncement date: September 16, 2026Prior intimation date: July 29, 2026
📅 Short termInitial operational drag is typical for new hospital units due to fixed overheads before patient volumes ramp up over 2–4 quarters.
📈 Long termStrengthens the company's hub-and-spoke healthcare network across Andhra Pradesh, driving incremental volume and brand loyalty in tier-2 markets.
⚠ Risk flags
- Initial gestation losses and low initial bed occupancy during ramp-up
Key Highlights
Commenced operations at a 50-bed women's and children's hospital in Guntur, Andhra Pradesh
Operational milestone achieved pursuant to earlier intimation dated July 29, 2026
Adds to the company's regional South Indian network
👀 What to Watch
Track occupancy ramp-up, ARPOB trends, and the gestational break-even period for the new Guntur facility in upcoming quarterly filings.
Rainbow Children's Medicare CFO Vikas Maheshwari Resigns Effective August 31, 2026
Rainbow Children's Medicare Limited announced the resignation of its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), Mr. Vikas Maheshwari, effective August 31, 2026, due to personal reasons. The Board accepted the resignation via circular resolution on August 25, 2026. The company stated that it has already identified a prospective successor for the CFO role, with the appointment pending formal procedures. The company reported TTM revenues of Rs 1,820 Cr and net profit of Rs 290 Cr.
Confidence: HIGH
What changedVikas Maheshwari is stepping down as CFO of Rainbow Children's Medicare on August 31, 2026; a successor candidate has been identified.
Why it mattersCFO transitions are critical for capital allocation and hospital expansion plans, though operational impact is mitigated by having a replacement candidate identified.
Effective cessation date: August 31, 2026Board resolution date: August 25, 2026TTM Revenue: Rs 1820 CrMarket Cap: Rs 14923 Cr
📅 Short termShort-term impact is expected to be minimal as transition planning is already underway with an identified prospective candidate.
📈 Long termLimited operational disruption provided the successor integrates smoothly and maintains financial discipline across regional hospital expansions.
⚠ Risk flags
- Key management transition risk pending appointment and onboarding of the new CFO
Key Highlights
Resignation of CFO and KMP Mr. Vikas Maheshwari effective August 31, 2026
Board approved resignation by circulation on August 25, 2026
Departure stated to be due to personal reasons with no other material reasons cited
Prospective candidate for the CFO position has been identified pending final formalities
👀 What to Watch
Track the upcoming disclosure announcing the formal appointment and profile of the new Chief Financial Officer.
Bohra Industries Q1 Net Loss at ₹56.55 Lakh; Operational Revenue Remains at Nil
Bohra Industries reported standalone revenue from operations of Nil for the quarter ended June 30, 2026, continuing a multi-quarter trend of inactive commercial operations. The standalone net loss narrowed to ₹56.55 lakh compared to a loss of ₹69.31 lakh in Q1 FY26 and a loss of ₹103.43 lakh in Q4 FY26. Total expenses came in at ₹56.55 lakh, dominated by depreciation (₹33.08 lakh) and other expenses (₹16.81 lakh). The board also approved the induction of two new Independent Directors, Dr. Kuncheria P. Isaac and Mr. Ankaj Kumar Mishra, for 5-year tenures.
Confidence: HIGH
What changedBohra Industries filed its Q1 FY27 financial results reporting continued zero revenue alongside the appointment of two independent board directors.
Why it mattersThe company continues to run at an operational standstill, incurring quarterly cash and non-cash expenses that gradually erode equity value.
Revenue from operations (Q1 FY27): NilNet Loss (Q1 FY27): ₹56.55 lakhDepreciation expense: ₹33.08 lakhPaid-up equity capital: ₹2,117.22 lakhBasic EPS: ₹-0.27
📅 Short termPerformance will remain muted as the company displays no active operating sales.
📈 Long termLimited operational viability until the core manufacturing setup is revived or fresh capital is infused into functional business operations.
⚠ Risk flags
- Continuous zero operational revenue
- Persistent quarterly losses eroding net worth
- Subdued business activity and lack of clear operational recovery timeline
Key Highlights
Revenue from operations remained at Nil for the quarter ended June 30, 2026.
Net loss for the quarter stood at ₹56.55 lakh against a net loss of ₹69.31 lakh in Q1 FY26.
Depreciation of ₹33.08 lakh accounted for 58.5% of total quarterly expenses of ₹56.55 lakh.
Basic and diluted EPS stood at ₹-0.27 for the quarter compared to ₹-0.33 in Q1 FY26.
Appointed two Independent Directors for a 5-year term ending August 13, 2031, subject to shareholder approval.
👀 What to Watch
Monitor future corporate updates for any sign of operational restart or commercial fertilizer production, as the business currently generates zero operational turnover.
64% Stake Acquisition Completed in Super Prime Medical Care LLP
Rainbow Children’s Medicare Limited has successfully completed the acquisition of a 64% partnership interest in Super Prime Medical Care LLP on August 14, 2026. This follows the initial Partnership Interest and Contribution Transfer Agreement (PICTA) signed on July 29, 2026. While the transaction value was not disclosed in this filing, the company is utilizing its strong net cash position of ₹560 crore to fund its inorganic growth strategy. This acquisition is part of Rainbow's broader plan to scale its specialized pediatric and maternal care network.
Confidence: HIGH
What changedRainbow has moved from a definitive agreement to full completion of a 64% majority stake in Super Prime Medical Care LLP.
Why it mattersThis acquisition expands Rainbow's clinical footprint and capacity, contributing to its goal of becoming a national player in pediatric super-specialty care while utilizing its debt-light balance sheet.
Stake Acquired: 64%Completion Date: August 14, 2026Agreement Date: July 29, 2026Company Net Cash: ₹560 crTTM Revenue: ₹1820 cr
📅 Short termThe completion of the acquisition is a positive milestone that confirms management's execution of its inorganic growth pipeline.
📈 Long termStructurally significant as it adds to the company's bed capacity and helps diversify its geographic presence beyond its core Hyderabad market.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Integration risk of the new LLP
- Potential short-term margin dilution if the acquired unit's ARPOB is lower than the group average
Key Highlights
Completed acquisition of 64% partnership interest and capital contribution in Super Prime Medical Care LLP.
The transaction was finalized on August 14, 2026, following the agreement dated July 29, 2026.
Acquisition aligns with the company's strategy to leverage its ₹560 crore net cash for scaling operations.
The move supports the company's target of driving 25% growth in newer units through integration of M&A assets.
👀 What to Watch
Investors should monitor the integration timeline and the impact of this acquisition on consolidated occupancy rates (currently 50.53%) and ARPOB in the next two quarterly earnings cycles.
Cerebra Integrated Reports ₹6.46 Cr Q1 Loss; Files for NCLT Insolvency (CIRP)
Cerebra Integrated Technologies reported a severe 82% YoY decline in Q1 FY27 revenue to ₹0.32 Cr, down from ₹1.79 Cr. The company posted a net loss of ₹6.46 Cr for the quarter and has filed for Corporate Insolvency Resolution Process (CIRP) under Section 10 of the IBC on June 15, 2026. Auditors have issued a disclaimer of conclusion, citing material uncertainties about the company's ability to continue as a going concern, exacerbated by a 99.9% delinquency rate in trade receivables (₹142.46 Cr overdue for >1 year).
Confidence: HIGH
What changedThe company has formally initiated insolvency proceedings under the IBC and reported a near-total collapse in operational revenue.
Why it mattersThe business is in a terminal survival crisis with stalled operations, massive unrecoverable debt, and a total breakdown of internal financial controls, making it a high-risk entity for equity holders.
Q1 Revenue: ₹32.26 LakhsQ1 Net Loss: ₹6.46 CrReceivables > 1 year: ₹142.46 CrNCLT Filing Date: 15 June 2026Promoter Holding: 0.8%
📅 Short termThe stock is likely to face extreme volatility or trading suspensions as the NCLT process for insolvency begins.
📈 Long termThe company's future is entirely dependent on the outcome of the insolvency resolution process; current operations are structurally non-viable.
⚠ Risk flags
- Insolvency filing (CIRP) under IBC
- Auditor Disclaimer of Conclusion
- 99.9% receivable delinquency rate
- Near-zero promoter holding (0.8%)
- Cessation of key refurbishment operations
Key Highlights
Revenue from operations collapsed by 82% YoY to ₹32.26 Lakhs in Q1 FY27.
Net loss for the quarter stood at ₹6.46 Cr, while finance costs remained high at ₹1.98 Cr.
Company filed for insolvency (CIRP) under Section 10 of IBC on June 15, 2026, pending NCLT Bengaluru approval.
Trade receivables of ₹142.46 Cr are outstanding for more than one year, with no provision for expected credit loss.
Overseas dues of ₹100.28 Cr from the sale of a former subsidiary are now overdue for more than 2 years.
👀 What to Watch
Monitor the NCLT Bengaluru bench's decision regarding the admission of the CIRP application. Investors should be extremely cautious given the auditor's disclaimer, the insolvency filing, and the negligible promoter holding of 0.8%.
Rain Industries Q2 2026: Carbon Utilization at 69%, 15k MT Deferred Shipments to Recover in Q3
Rain Industries provided management commentary on Q2 2026 results, highlighting a 10% volume decline in the Carbon segment due to 10,000-15,000 metric tonnes of deferred shipments. Despite lower volumes, utilization remained stable at 69%, and management expects a recovery in Q3 alongside the restart of a US-based kiln. Employee expenses surged 32% YoY, driven by performance-linked incentive provisions and significant currency depreciation (USD up 10.7% vs INR). The company is prioritizing debt reduction, targeting a net-debt-to-EBITDA ratio of 3x while evaluating bond refinancing opportunities.
Confidence: HIGH
What changedManagement clarified that the Q2 volume weakness was due to timing (deferred shipments) rather than structural demand loss, and explained the spike in employee costs as a performance-linked normalization.
Why it mattersThe commentary provides confidence that margins are resilient despite 'opportunistic' gains in Q2, and confirms the company's focus on deleveraging and capacity expansion in the cement and carbon sectors.
Carbon Segment Utilization: 69%Deferred Shipments: 10,000 to 15,000 MTEmployee Expense Increase (YoY): 32%USD Appreciation vs INR: 10.7%Target Net-Debt-to-EBITDA: 3xCement Capacity Expansion: 53%
📅 Short termThe stock may see neutral to slightly positive sentiment as management clarifies that volume misses are temporary and that Q3 should see a normalization of shipments.
📈 Long termStructural growth remains tied to the 2.3 MTPA cement expansion and the pivot toward Battery Anode Materials (BAM) for the EV market, alongside disciplined debt management.
⚠ Risk flags
- Geopolitical tensions impacting logistics
- Currency volatility (USD/Euro vs INR)
- Raw material (GPC) price spikes
Key Highlights
Carbon segment utilization maintained at 69% in Q2 2026, despite a 10% YoY volume drop.
Deferred shipments impacted the quarter by approximately 10,000 to 15,000 metric tonnes, expected to recover in Q3.
Employee expenses increased 32% YoY due to incentive provisions and USD/Euro appreciation of 10.7% and 13.5% respectively.
Management targets a long-term net-debt-to-EBITDA leverage ratio of 3x.
Cement capacity is on track to expand by 53% to 6.6 MTPA via brownfield projects.
👀 What to Watch
Watch for the realization of deferred volumes in the Q3 FY26 results and the operational status of the restarted US kiln. Monitor any formal refinancing announcements regarding the company's bonds to assess potential interest cost savings.
Q2 2026 Results: Adjusted EBITDA Surges 61% YoY to ₹9.94 Bn; Revenue Up 17%
Rain Industries (RAIN) reported a strong Q2 2026 with consolidated revenue from operations reaching ₹51.67 Bn, a 17% increase YoY. Adjusted EBITDA grew significantly by 61% to ₹9.94 Bn, driven by raw material blend optimization in the Carbon segment and pricing increases in Advanced Materials. The company's leverage improved, with the Net Debt to EBITDA ratio falling to 2.77x from 3.21x in December 2025. However, the Cement segment faced headwinds, with revenue declining to ₹2.97 Bn due to intense competition and lower price realizations.
Confidence: HIGH
What changedRAIN has demonstrated a significant recovery in operational margins and deleveraging, moving from a Net Debt/EBITDA of 3.21x to 2.77x within six months.
Why it mattersThe sharp increase in EBITDA despite volume pressures in some segments indicates improved pricing power and cost-saving initiatives, which are critical for maintaining profitability in a volatile commodity environment.
Q2 Revenue from Operations: ₹51.67 BnAdjusted EBITDA Growth: 61% YoYAdjusted EPS (Q2): ₹9.43Net Debt to EBITDA: 2.77xH1 2026 Capex: US$ 26 Mn
📅 Short termThe stock may react positively to the substantial EBITDA growth and margin expansion, alongside improved leverage metrics.
📈 Long termLong-term value depends on the successful pivot toward Battery Anode Materials (BAM) and the scaling of the 53% cement capacity expansion to 6.6 MTPA.
⚠ Risk flags
- Geopolitical disruptions affecting trade routes
- Increased competition in the South Indian cement market
- Volatility in Brent oil and Natural Gas prices impacting input costs
Key Highlights
Adjusted EBITDA increased 61% YoY to ₹9.94 Bn, with margins expanding to 19.2% from 14.0% in Q2 2025.
Carbon segment revenue rose to ₹37.70 Bn, benefiting from higher prices and currency appreciation (Euro/USD vs INR).
Net Debt to EBITDA ratio improved to 2.77x, with no significant term debt maturities until October 2028.
Total liquidity remains robust at US$ 313 million, including US$ 172 million in cash and cash equivalents.
Cement segment volumes decreased to 651,000 MT from 699,000 MT in Q2 2025 due to market competition.
👀 What to Watch
Investors should monitor the execution of the 2.3 MTPA cement capacity expansion and the commencement of Indian carbon distillation operations in H2 FY26. Watch for the impact of geopolitical trade route disruptions on logistics costs in the upcoming quarter.
61% EBITDA Growth in Q2 2026; Revenue hits ₹5,167 Cr driven by Carbon segment
Rain Industries reported a strong Q2 2026 with revenue growing 17% YoY to ₹5,167 Cr and Adjusted EBITDA surging 61% to ₹994 Cr. The Carbon segment was the primary driver, benefiting from raw material blend optimization and cost savings, while the Cement segment faced headwinds from competition and lower realizations. Adjusted PAT stood at ₹317 Cr with an EPS of ₹9.43. The company maintains a healthy liquidity position of US$313 Mn with no significant debt maturities until October 2028.
Confidence: HIGH
What changedSignificant improvement in operational profitability (EBITDA) and debt-to-EBITDA leverage compared to the previous year, despite volume pressures in the cement segment.
Why it mattersDemonstrates the company's ability to optimize costs and leverage its global carbon footprint despite volatility in the cement segment and global logistics; the improved leverage ratio reduces financial risk.
Q2 Revenue: ₹5,167 CrQ2 Adjusted EBITDA: ₹994 CrEBITDA Margin: 19.2%Net Debt to EBITDA: 2.77xTotal Liquidity: US$313 Mn
📅 Short termPositive reaction likely due to the 61% EBITDA jump and margin expansion, though management's cautious Q3 outlook regarding geopolitical and logistics volatility may temper enthusiasm.
📈 Long termStructural improvements in the Carbon segment and the pivot toward Battery Anode Materials (BAM) for the EV market are key long-term value drivers, alongside the 53% capacity expansion in Cement.
⚠ Risk flags
- Geopolitical disruptions affecting trade routes
- Commodity price volatility (GPC prices)
- Intense competition in the South Indian cement market
Key Highlights
Revenue from operations increased 17% YoY to ₹51.67 Bn in Q2 2026
Adjusted EBITDA grew 61% YoY to ₹9.94 Bn, with margins improving to 19.2% from 14.0%
Carbon segment volumes reached 594k MT, contributing ₹8.11 Bn to Adjusted EBITDA
Net Debt to EBITDA ratio improved to 2.77x in June 2026 from 3.21x in December 2025
Cement segment revenue declined to ₹2.97 Bn due to increased competition and lower price realizations
👀 What to Watch
Monitor the stabilization of raw material costs and the progress of the 2.3 MTPA cement capacity expansion, as well as the commencement of Indian carbon distillation operations in H2 FY26.
Rs 1.00 Interim Dividend: Rain Industries Sets August 28, 2026, as Payment Date
Rain Industries has confirmed that the interim dividend of Rs 1.00 per equity share for the financial year ending December 31, 2026, will be paid on August 28, 2026. This dividend represents a 50% payout on the face value of Rs 2.00 per share. At the current market price of Rs 243.0, this specific interim payout translates to a yield of approximately 0.41%. The announcement follows a period where the company reported a TTM PAT of Rs 310 Cr and is currently undergoing a significant 53% capacity expansion in its cement business.
Confidence: HIGH
What changedThe company has finalized and announced the specific disbursement date for its interim dividend for the 2026 financial year.
Why it mattersIt provides a clear timeline for cash distribution to shareholders, demonstrating a consistent return of capital despite the company's capital-intensive expansion phase in the cement and carbon segments.
Dividend per share: Rs 1.00Dividend as % of Face Value: 50%Payment Date: August 28, 2026Yield (this interim dividend): 0.41%Face Value: Rs 2.00
📅 Short termThe stock is likely to see routine price adjustments around the ex-dividend date; the payment date provides a clear liquidity timeline for shareholders.
📈 Long termLimited structural impact from this specific announcement. Long-term value depends on the successful 2.3 MTPA cement expansion and R&D into Battery Anode Materials.
Key Highlights
Interim dividend declared at Rs 1.00 per equity share for FY2026.
Dividend payout is 50% of the face value of Rs 2.00 per share.
Scheduled payment date for eligible shareholders is August 28, 2026.
Company maintains a January to December financial year cycle.
👀 What to Watch
Investors should ensure their bank mandates are updated with the depository to receive the credit on August 28. Focus should remain on the upcoming H2 FY26 commencement of Indian carbon distillation operations for fundamental growth.
Aug 14, 2026 Fixed as Record Date for Interim Dividend
Rain Industries has fixed August 14, 2026, as the record date to determine shareholder eligibility for an interim dividend for the financial year ending December 31, 2026. The decision was finalized during a board meeting held on August 6, 2026. While the specific dividend amount per share was not disclosed in this filing, the company reported a TTM PAT of Rs 310 Cr. This corporate action follows a strong 80.5% price return over the last three months.
Confidence: HIGH
What changedThe company has established the formal timeline for its interim dividend distribution for the current financial year.
Why it mattersIt represents a cash return to shareholders, supported by a TTM PAT of Rs 310 Cr, though the company's ROCE remains low at 2.0%.
Record Date: August 14, 2026Board Meeting Date: August 6, 2026TTM PAT: Rs 310 CrDividend Amount: not disclosed
📅 Short termThe stock may see minor price adjustments around the ex-dividend date (typically one day prior to the record date) as the dividend value is factored out.
📈 Long termLimited; routine dividend payments are standard for the company, while long-term value depends on the 2.3 MTPA cement capacity expansion and BAM R&D.
Key Highlights
Record date for interim dividend eligibility set for August 14, 2026
Board meeting for approval conducted on August 6, 2026
Dividend applies to the financial year ending December 31, 2026
Company maintains a TTM revenue of Rs 9,310 Cr and OPM of 26.4%
👀 What to Watch
Investors should monitor for the specific dividend amount per share and ensure holdings are settled in their demat accounts by the August 14 record date.
₹1.00 Interim Dividend Declared by Rain Industries; Record Date August 14, 2026
Rain Industries has declared an interim dividend of ₹1.00 per equity share for the financial year ending December 31, 2026. This represents a 50% payout on the face value of ₹2 per share, with a total outflow of ₹336.35 million (approx. ₹33.64 Cr). The board has fixed August 14, 2026, as the record date for determining shareholder eligibility. This announcement accompanied the release of the Q2 2026 financial results, where the company reported consolidated revenue of ₹5,167.16 Cr (51,671.58 million).
Confidence: HIGH
What changedThe company has declared its first interim dividend for the 2026 financial year and confirmed the re-appointment of a key independent director.
Why it mattersThe dividend reflects a consistent capital return policy, representing a payout of approximately 10.8% of TTM PAT. While the yield is modest at ~0.4%, it signals management's confidence in liquidity despite ongoing brownfield expansions.
Dividend per share: ₹1.00Dividend Yield: 0.41%Total Payout: ₹336.35 millionRecord Date: August 14, 2026Q2 Revenue (Consolidated): ₹5,167.16 Cr
📅 Short termThe stock is expected to trade with a neutral-to-positive bias leading up to the record date, with a standard price adjustment on the ex-dividend date.
📈 Long termLimited structural impact from the dividend itself; long-term value remains tied to the 2.3 MTPA cement expansion and the commissioning of the Indian carbon distillation operations.
Key Highlights
Interim dividend of ₹1.00 per equity share (50% of face value of ₹2).
Total dividend payout aggregating to ₹336.35 million (~₹33.64 Cr).
Record date for dividend eligibility set for August 14, 2026.
Consolidated revenue for the quarter ended June 30, 2026, reached ₹5,167.16 Cr.
Re-appointment of Mr. Robert Thomas Tonti as Independent Director for a 5-year term starting October 31, 2026.
👀 What to Watch
Investors should note the record date of August 14, 2026; the stock will typically trade ex-dividend one business day prior. Monitor the upcoming full Q2 earnings analysis for operational performance in the Carbon and Cement segments.
Rs 1.00 Interim Dividend Declared as RAIN Reports Q2 Revenue of Rs 5,167 Cr
Rain Industries reported a strong Q2 FY26 with consolidated revenue reaching Rs 5,167.16 Cr, a 14.3% increase over the preceding quarter (Rs 4,520.73 Cr). The Board declared an interim dividend of Rs 1.00 per share (50% of face value) with a record date of August 14, 2026. Profit Before Tax (PBT) for the quarter stood at Rs 501.07 Cr, nearly doubling from the Rs 255.78 Cr reported in Q1 FY26. The Carbon segment remains the dominant contributor, accounting for approximately 78% of total segment revenue.
Confidence: HIGH
What changedRain Industries has reported its Q2 FY26 results showing significant QoQ profit growth and declared an interim dividend of Rs 1.00 per share.
Why it mattersThe results indicate a strong operational recovery in the Carbon segment and provide immediate cash returns to shareholders, supporting the stock's recent positive momentum.
Q2 FY26 Revenue: Rs 5,167.16 CrQ2 FY26 PBT: Rs 501.07 CrInterim Dividend: Rs 1.00 per shareDividend Record Date: August 14, 2026H1 FY26 PBT Growth (YoY): 326%
📅 Short termThe stock is likely to react positively to the sequential earnings growth and the dividend announcement leading up to the August 14 record date.
📈 Long termLong-term value depends on the successful pivot to Battery Anode Materials (BAM) and the 53% capacity expansion in the cement segment to 6.6 MTPA.
⚠ Risk flags
- Geopolitical tensions impacting trade routes
- High client concentration in the aluminum industry (42% of revenue)
- Volatility in GPC prices affecting carbon segment margins
Key Highlights
Consolidated revenue for Q2 FY26 reached Rs 5,167.16 Cr, up from Rs 4,520.73 Cr in Q1 FY26.
Interim dividend of Rs 1.00 per equity share (50% on face value of Rs 2) declared for FY26.
H1 FY26 Profit Before Tax (PBT) surged to Rs 756.84 Cr compared to Rs 177.64 Cr in H1 FY25.
Carbon segment revenue grew to Rs 4,021.13 Cr in Q2 FY26 from Rs 3,527.63 Cr in the previous quarter.
Record date for the interim dividend is fixed for August 14, 2026.
👀 What to Watch
Monitor the commencement of Indian carbon distillation operations in H2 FY26 and the progress of the 2.3 MTPA cement capacity expansion, which is expected to drive FY27 growth.
Rainbow to invest ₹2,200 Cr to double capacity to 5,000 beds; Q1 revenue up 33%
Rainbow Children's Medicare reported a strong start to FY27 with Q1 revenue growing 33% YoY and EBITDA increasing 29.9%. The management announced an aggressive 5-year expansion plan to add 2,500 beds, doubling its total capacity to 5,000 beds with a projected capex of ₹2,200 crore. The company is expanding its footprint into Western India with a 100-bed hospital in Mumbai (Malad) and is on track to commence Indore operations in Q3 FY27. The strategy emphasizes larger hospital formats (80+ beds) to maintain clinical excellence in pediatric super-specialties.
Confidence: HIGH
What changedThe company has formalized a massive 5-year growth roadmap to double its capacity and announced its first major entry into the Western India market (Mumbai).
Why it mattersThe ₹2,200 crore capex is significant, representing approximately 130% of the company's current net worth (₹1,690 Cr), signaling a transition from a regional leader to a national pediatric healthcare player.
Q1 Revenue Growth (YoY): 33%Planned 5-Year Capex: ₹2,200 crCapex vs Net Worth: ~130%Target Bed Capacity: 5,000 bedsBeds under development: 1,200 beds
📅 Short termThe stock may react positively to the strong 33% revenue growth and the clear, funded expansion roadmap provided by the management.
📈 Long termThe structural shift to a 5,000-bed national network could significantly re-rate the company if it successfully replicates its South India clinical model in North and West India.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk in new geographies (Mumbai, Indore)
- Gestation period of new units potentially impacting near-term margins
- High capex intensity
Key Highlights
Revenue grew by 33% YoY in Q1 FY27, driven by both mature and new facilities.
Planned capex of ₹2,200 crore over 5 years to add 2,500 beds, reaching a 5,000-bed total capacity.
Visibility established for 1,200 beds currently under various stages of development.
Entry into Mumbai market with a 100-bed brownfield hospital in Malad expected by Q1 FY28.
Acquisition of 70-bed Prime Children's Hospital in Nellore and a 50-bed lease in Guntur to strengthen the AP cluster.
👀 What to Watch
Watch for the timely commencement of the Indore facility in Q3 FY27 and the Mumbai facility in Q1 FY28 as key indicators of successful geographic diversification beyond South India.
18.8% Revenue Growth and PBT Turnaround to ₹0.14 Cr in Q1 FY'27
Indian Terrain Fashions reported a revenue of ₹81.74 Cr for Q1 FY'27, an 18.8% increase YoY. The company achieved a significant operational turnaround, reporting a Profit Before Tax (PBT) of ₹0.14 Cr compared to a loss of ₹6.04 Cr in the same quarter last year. EBITDA surged by 233.5% to ₹7.57 Cr, while Gross Margins expanded by 193 bps to 41.0%. Although the company remains marginally loss-making at the PAT level (₹-0.83 Cr), this represents an 86.6% improvement YoY.
Confidence: HIGH
What changedThe company has transitioned from significant operating losses to a positive PBT and improved its working capital cycle by 33 days.
Why it mattersFor a micro-cap company with a market cap of ₹141 Cr and a history of losses, this operational turnaround is critical for survival and potential re-rating if sustained.
Revenue (Q1 FY27): ₹81.74 CrRevenue vs TTM Revenue: 21.6%EBITDA Growth: 233.5%Gross Margin: 41.0%Working Capital Days: 294 days
📅 Short termThe stock may see positive momentum as the company has demonstrated a turnaround at the PBT level and strong EBITDA growth.
📈 Long termThe company's strategy of store rationalization and focusing on profitable channels like EBOs and online is showing results, but long-term sustainability depends on consistent PAT growth.
⚠ Risk flags
- High working capital cycle (294 days)
- Continued Net Loss (PAT) of ₹0.83 Cr
- Relatively low promoter holding at 31.6%
Key Highlights
Revenue from operations increased 18.8% YoY to ₹81.74 Cr.
EBITDA grew 233.5% YoY to ₹7.57 Cr, with margins improving significantly.
Profit Before Tax turned positive at ₹0.14 Cr vs a loss of ₹6.04 Cr in Q1 FY'26.
Gross Working Capital Days improved to 294 days from 327 days in the previous year.
Exclusive store count stands at 176 as of June 2026, reflecting a rationalized retail footprint.
👀 What to Watch
Investors should monitor if the company can maintain PBT positivity and transition to a positive Net Profit (PAT) in upcoming quarters. The reduction in working capital days is a positive sign for liquidity management.
18.8% Revenue Growth and Return to Positive PBT in Q1 FY'27
Indian Terrain Fashions reported a strong Q1 FY'27 with revenue growing 18.8% YoY to ₹81.74 Cr. The company achieved a significant turnaround at the Profit Before Tax (PBT) level, posting ₹0.14 Cr compared to a loss of ₹6.04 Cr in the same quarter last year. This was driven by a 193 bps expansion in gross margins to 41.0% and a 233.5% surge in EBITDA to ₹7.57 Cr. Operational efficiency improved as inventory days dropped from 81 to 65, and gross working capital days reduced by 33 days YoY.
Confidence: HIGH
What changedThe company has moved from a loss-making phase to operational profitability (PBT positive) while simultaneously reducing inventory and working capital cycles.
Why it mattersFor a small-cap company (₹141 Cr market cap) that has struggled with losses, this turnaround in margins and working capital efficiency is critical for long-term solvency and potential re-rating.
Q1 Revenue: ₹81.74 CrQ1 PBT: ₹0.14 CrGross Margin: 41.0%Inventory Days: 65 daysOrder Book Growth (SS'27): 15-20%Q1 Revenue vs TTM Revenue: 21.6%
📅 Short termThe stock may see positive sentiment as the company demonstrates a return to profitability and improved operational metrics despite a cautious consumer environment.
📈 Long termIf the company sustains its focus on high-productivity channels and maintains working capital discipline, it could structurally improve its return profile over the next 2-3 years.
⚠ Risk flags
- High gross working capital at 294 days
- Vulnerability to rising freight and raw material (cotton) costs
- Dependency on discretionary consumer spending which softened in mid-May
Key Highlights
Revenue from operations increased 18.8% YoY to ₹81.74 Cr, representing ~21.6% of TTM revenue.
Turned around from a PBT loss of ₹6.04 Cr in Q1 FY'26 to a positive PBT of ₹0.14 Cr.
Gross margin expanded by 193 basis points to 41.0% through disciplined merchandising and channel optimization.
Inventory levels improved significantly, reducing from 81 days to 65 days YoY.
Forward visibility strengthened with SS'27 roadshow order bookings reported up 15-20%.
👀 What to Watch
Watch for the company's ability to translate positive PBT into consistent Net Profit (PAT) in the upcoming festive quarters and monitor the impact of rising freight costs on margins.
18.8% Revenue Growth and Return to Positive PBT in Q1 FY'27
Indian Terrain Fashions reported a turnaround in operational performance for Q1 FY'27, with revenue growing 18.8% YoY to ₹81.74 Cr. The company achieved a positive Profit Before Tax (PBT) of ₹0.14 Cr, a significant recovery from a ₹6.04 Cr loss in the same quarter last year. Gross margins expanded by 193 bps to 41.0%, supported by disciplined merchandising and channel optimization. Efficiency gains were also visible in the working capital cycle, with gross working capital days reducing by 33 days YoY to 294 days.
Confidence: HIGH
What changedThe company has successfully transitioned from a loss-making position to positive PBT while simultaneously reducing inventory days from 81 to 65.
Why it mattersFor a micro-cap company with a ₹141 Cr market cap and recent losses, achieving operational profitability and improving working capital efficiency is critical for financial stability and potential re-rating.
Q1 Revenue: ₹81.74 CrQ1 PBT: ₹0.14 CrGross Margin: 41.0%Inventory Days: 65 daysOrder Book Growth: 15-20%Q1 Revenue vs TTM Revenue: 21.6%
📅 Short termThe stock may see positive sentiment as the company returns to profitability and demonstrates better inventory management.
📈 Long termStructural shifts toward an omni-channel model (online now 13% of revenue) and a leaner working capital cycle could improve long-term return ratios if revenue growth sustains.
⚠ Risk flags
- High debtor days (254 days per financial context)
- Rising freight costs due to West Asia conflict
- Renewed upward pressure on cotton and synthetic fiber prices
Key Highlights
Revenue from operations increased 18.8% YoY to ₹81.74 Cr.
EBITDA surged 233.5% YoY to ₹7.57 Cr with a 9.26% margin.
Gross margin expanded by 193 basis points to reach 41.0%.
Gross working capital days reduced by 33 days YoY to 294 days.
Forward visibility improved with roadshow order bookings up by 15-20%.
👀 What to Watch
Monitor the company's ability to maintain positive PBT through the upcoming festive season and track the impact of rising freight and raw material costs on margins.
₹81.74 Cr Q1 Revenue: Indian Terrain Narrows Net Loss to ₹0.83 Cr, PBT Turns Positive
Indian Terrain Fashions reported a 18.8% YoY increase in revenue to ₹81.74 Cr for Q1 FY27. The company achieved a turnaround at the operational level with a Profit Before Tax (PBT) of ₹0.14 Cr, compared to a loss of ₹6.04 Cr in the same quarter last year. However, due to a deferred tax charge of ₹0.97 Cr, the company reported a net loss of ₹0.83 Cr, which is still a significant improvement from the ₹6.19 Cr loss in Q1 FY26. Finance costs remain a heavy burden at ₹4.51 Cr, nearly equal to the company's employee and depreciation costs combined.
Confidence: HIGH
What changedThe company has transitioned from a significant operational loss to a marginal operational profit (PBT) on a year-on-year basis, despite a sequential revenue decline from Q4 FY26.
Why it mattersFor a micro-cap company with a market cap of ₹141 Cr and a history of losses, achieving positive PBT is a critical milestone for financial recovery and debt servicing capability.
Q1 Revenue vs TTM Revenue: ~21.6%Revenue from Operations: ₹81.74 CrNet Loss: ₹0.83 CrFinance Costs: ₹4.51 CrPBT: ₹0.14 Cr
📅 Short termThe significant narrowing of losses and positive PBT are likely to be viewed positively by the market in the short term, reflecting improved operational efficiency.
📈 Long termStructural recovery depends on the company's ability to manage its high debt (₹102 Cr) and improve working capital cycles, as finance costs currently consume most of the operating profit.
⚠ Risk flags
- High finance costs relative to operating profit
- High debtor days (254 days as per context)
- Continued net loss despite positive PBT
Key Highlights
Revenue from operations increased 18.8% YoY to ₹81.74 Cr from ₹68.78 Cr.
Net loss narrowed by 86.6% YoY to ₹0.83 Cr from ₹6.19 Cr.
Profit Before Tax (PBT) turned positive at ₹0.14 Cr vs a loss of ₹6.04 Cr in the year-ago period.
Finance costs remained high at ₹4.51 Cr, representing 5.5% of quarterly revenue.
The 17th Annual General Meeting (AGM) is scheduled for September 10, 2026.
👀 What to Watch
Watch for the company's ability to sustain positive PBT in the coming quarters and whether the exit from the boys' wear segment leads to better inventory management and reduced debtor days.
